Brendan P. Eckelman - Chief Scientific Officer at Inhibrx Biosciences, Inc.

Issuer-level insider activity

Role: Chief Scientific Officer
Issuer ticker: INBX on Nasdaq
Entity type: Individual
Source filing history: Open source filing history

No buys or sells have been reported by Brendan P. Eckelman since 09 Aug 2025

Reported holdings for Brendan P. Eckelman in Inhibrx Biosciences, Inc.

Form 4 holding Chief Scientific Officer

Inhibrx Biosciences, Inc.

Security class: Common Stock
Shares / value: 433,888
Estimated value: $5,610,172
Report date: 29 May 2024
Price: $12.93
Ownership: By the Eckelman Living Trust Dated February 5, 2014

Form 4 holding Chief Scientific Officer

Inhibrx Biosciences, Inc.

Security class: Common Stock
Shares / value: 40,000
Estimated value: $517,200
Report date: 29 May 2024
Price: $12.93
Ownership: By trust

Form 4 holding Chief Scientific Officer

Inhibrx Biosciences, Inc.

Security class: Stock Option (right to buy)
Shares / value: 175,000
Estimated value
Report date: 30 May 2024
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Transaction history for Brendan P. Eckelman in Inhibrx Biosciences, Inc.

Sym	Class	Transaction	%	SEC-reported value	SEC-reported price	Shares	Shares after	Date	Ownership

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .